The European Union has told Pfizer and other drug companies that they must secure its permission before exporting vaccine doses to Britain amid concerns about the level of supply.
Brussels announced plans yesterday for new controls on the export of vaccines in response to public anger at the slow pace of immunisation programmes in the EU. Companies will have to provide “early notification” of exports of all vaccines manufactured in the bloc to try to prevent shortages.
The intervention will raise fears that Britain’s supplies of the Pfizer-Biontech vaccine, which is made in Belgium, could be disrupted. Germany has suggested that vaccine exports could be blocked to safeguard supplies within the EU.
Britain has ordered 40 million doses of the Pfizer-Biontech vaccine, which is one